Business Standard

US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
Premium

SII plans to make around 300 mn doses of the Oxford Astrazeneca vaccine by December

Jeff Mason and Carl O'Donnell | Reuters
The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential Covid-19 vaccine for around $1.5 billion (£1.15 billion), the company and White House said on Tuesday.

The United States in recent weeks has made deals to acquire hundreds of millions of doses of potential Covid-19 vaccines from several companies as part of its Operation Warp Speed program, which aims to deliver a vaccine in the country by the end of the year.

Moderna's price per dose comes to around $30.50 per person for a two dose regimen.

With the exception of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in